 Bioverativ

Bioverativ Inc. is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk.